These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Cytomegalovirus Reactivation in Patients with Sepsis in an Intensive Care Unit in Portugal. Paixão P; Ramos P; Piedade C; Casado A; Chasqueira M Acta Med Port; 2020 Sep; 33(9):576-582. PubMed ID: 32498761 [TBL] [Abstract][Full Text] [Related]
10. Looking for biological factors to predict the risk of active cytomegalovirus infection in non-immunosuppressed critically ill patients. Bravo D; Clari MA; Aguilar G; Belda J; Giménez E; Carbonell JA; Henao L; Navarro D J Med Virol; 2014 May; 86(5):827-33. PubMed ID: 24431153 [TBL] [Abstract][Full Text] [Related]
11. Interferon-γ production by CMV-specific CD8+ T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients. Castón JJ; Cantisán S; González-Gasca F; Páez-Vega A; Abdel-Hadi H; Illescas S; Alonso G; Torre-Cisneros J Intensive Care Med; 2016 Jan; 42(1):46-53. PubMed ID: 26537489 [TBL] [Abstract][Full Text] [Related]
13. Sepsis and cytomegalovirus: foes or conspirators? Mansfield S; Grießl M; Gutknecht M; Cook CH Med Microbiol Immunol; 2015 Jun; 204(3):431-7. PubMed ID: 25788396 [TBL] [Abstract][Full Text] [Related]
14. CMV in critically ill patients: pathogen or bystander? Limaye AP; Boeckh M Rev Med Virol; 2010 Nov; 20(6):372-9. PubMed ID: 20931610 [TBL] [Abstract][Full Text] [Related]
15. Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort study. van de Groep K; Nierkens S; Cremer OL; Peelen LM; Klein Klouwenberg PMC; Schultz MJ; Hack CE; van der Poll T; Bonten MJM; Ong DSY; Crit Care; 2018 Dec; 22(1):348. PubMed ID: 30563551 [TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus infection in critically ill patients: a systematic review. Osawa R; Singh N Crit Care; 2009; 13(3):R68. PubMed ID: 19442306 [TBL] [Abstract][Full Text] [Related]
17. Reactivated cytomegalovirus proctitis in an immunocompetent patient presenting as nosocomial diarrhea: a case report and literature review. Lee CY; Chen YH; Lu PL BMC Infect Dis; 2017 Feb; 17(1):113. PubMed ID: 28143418 [TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus and Epstein-Barr virus reactivation in the intensive care unit. Coşkun O; Yazici E; Şahiner F; Karakaş A; Kiliç S; Tekin M; Artuk C; Yamanel L; Beşirbellioğlu BA Med Klin Intensivmed Notfmed; 2017 Apr; 112(3):239-245. PubMed ID: 27435067 [TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Cytomegalovirus Reactivation and Association With Outcomes in Critically Ill Adults With Sepsis: A Pooled Analysis of Prospective Studies. Imlay H; Dasgupta S; Boeckh M; Stapleton RD; Rubenfeld GD; Chen Y; Limaye AP J Infect Dis; 2021 Jun; 223(12):2108-2112. PubMed ID: 33159200 [TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infections in non-immunocompromised and immunocompromised patients in the intensive care unit. Florescu DF; Kalil AC Infect Disord Drug Targets; 2011 Aug; 11(4):354-64. PubMed ID: 21679146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]